Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists
- PMID: 676925
Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists
Abstract
The vasomotor response of dopamine and dopaminergic agonists was studies on feline isolated middle cerebral arteries in vitro and pial arterioles in situ following microapplication. The action of various inhibitors was tested to define the receptors involved. The contractile response could be blocked by alpha-receptor as well as serotonin receptor antagonists. The mode of inhibition suggested that serotonin receptors rather than alpha-adrenoceptors mediated the dopamine-induced contraction. A dose-dependent dilation could be evoked by the dopaminergic agonists on actively contracting pial arteries in vitro and by apomorphine in situ. The relative potency for the agonists together with blocking experiments indicated that the vasodilation was mediated by specific dopamine receptors.
Similar articles
-
Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels.Acta Physiol Scand. 1978 Nov;104(3):349-59. doi: 10.1111/j.1748-1716.1978.tb06286.x. Acta Physiol Scand. 1978. PMID: 716985
-
[Analysis of the contraction induced by isoproterenol in isolated cerebral and femoral arteries of cat].Rev Esp Fisiol. 1982 Jun;38(2):155-60. Rev Esp Fisiol. 1982. PMID: 6289390 Spanish.
-
Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists.Br J Pharmacol. 1985 Jun;85(2):403-10. doi: 10.1111/j.1476-5381.1985.tb08875.x. Br J Pharmacol. 1985. PMID: 3896363 Free PMC article.
-
Relaxation by dopaminergic agonists in cerebral and peripheral arteries (in vitro).Arch Int Pharmacodyn Ther. 1981 Aug;252(2):196-209. Arch Int Pharmacodyn Ther. 1981. PMID: 7305558
-
Nerve endings and pharmacological receptors in cerebral vessels.Gen Pharmacol. 1982;13(5):361-8. doi: 10.1016/0306-3623(82)90100-8. Gen Pharmacol. 1982. PMID: 6757045 Review.
Cited by
-
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.Brain. 2011 Aug;134(Pt 8):2339-57. doi: 10.1093/brain/awr165. Epub 2011 Jul 19. Brain. 2011. PMID: 21771855 Free PMC article.
-
Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm. A case report.Interv Neuroradiol. 2002 Dec 22;8(4):409-15. doi: 10.1177/159101990200800410. Epub 2004 Oct 20. Interv Neuroradiol. 2002. PMID: 20594502 Free PMC article.
-
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.Neurobiol Dis. 2016 Dec;96:31-37. doi: 10.1016/j.nbd.2016.08.010. Epub 2016 Aug 17. Neurobiol Dis. 2016. PMID: 27544483 Free PMC article.
-
Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons.Front Neuroanat. 2014 Aug 26;8:84. doi: 10.3389/fnana.2014.00084. eCollection 2014. Front Neuroanat. 2014. PMID: 25206324 Free PMC article.
-
Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.Neuroimage. 2012 May 15;61(1):228-39. doi: 10.1016/j.neuroimage.2012.02.066. Epub 2012 Mar 3. Neuroimage. 2012. PMID: 22406356 Free PMC article.